The First One

The National Center for Advancing Translational Sciences is embarking on its first clinical trial, reports the Nature News Blog. The trial is examining a drug, called DEX-M74, for hereditary inclusion body myopathy, a condition that strikes young adults and for which there is no treatment, a press release adds.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.